TipRanks
Enveric Biosciences (DE:SLZ0)
FRANKFURT:SLZ0
Germany Market
SLZ0
Enveric Biosciences
RESEARCH TOOLSreports

Enveric Biosciences (SLZ0) Income Statement

1 Followers

Enveric Biosciences Income Statement

Last quarter (Q2 2026), Enveric Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Enveric Biosciences's net income was $-3.03M. See Enveric Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Mar 22
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -200.86K$ -337.49K$ -408.03K$ -435.20K$ -681.61K
Operating Expenses
$ 8.57M$ 9.29M$ 16.04M$ 19.53M$ 25.26M
Depreciation and Amortization
$ 200.86K$ 337.49K$ 408.03K$ 435.20K$ 681.61K
EBITDA
$ -8.57M$ -9.23M$ -16.85M$ -19.52M$ -55.74M
Operating Income
$ -8.77M$ -9.63M$ -16.45M$ -19.96M$ -25.94M
Other Income/Expenses
$ 2.46K$ 66.21K$ -814.38K$ 4.05K$ -30.49M
Pretax Income
$ -8.77M$ -9.57M$ -17.26M$ -19.96M$ -56.43M
Net Income
$ -12.13M$ -9.57M-$ -18.50M$ -48.98M
Per Share Metrics
Basic EPS
$ -36.24$ -228.48$ -97.08$ -156.00$ -1.24K
Diluted EPS
$ -36.24$ -228.48$ -97.08$ -156.00$ -1.24K
Weighted Average Shares Outstanding
 334.72K 41.91K 179.92K 173.19K 39.36K
Weighted Average Shares Outstanding (Diluted)
 334.72K 41.91K 179.92K 173.19K 39.36K
Currency in USD

Enveric Biosciences Earnings and Revenue History